Filed: 5/15/2024ACC: 0001420506-24-000943
📋 What this filing means
ALTIUM CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 72 equity positions with a total reported market value of $252.67M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
72
Positions
$252.67M
Total AUM (reported)
53.10M
Total Shares
Allocation by class
COM$145.31M57.5%
CL A$30.62M12.1%
COM NEW$27.82M11.0%
CALL$14.38M5.7%
PUT$14.37M5.7%
SPONSORED ADR$13.12M5.2%
COM PAR $.01$3.26M1.3%
Portfolio Concentration
Top 3$59.97M23.7%
4–10$68.64M27.2%
11–25$85.43M33.8%
Rest$38.63M15.3%
Top 3 weight
23.7%
Top 10 weight
50.9%
Voting Authority Distribution
Total shares with voting rights: 53.10M
Sole
Full voting authority
53.10M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole72
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings72
Rows:
VERA THERAPEUTICS INC
SOLEShares710K
TypeSH
Market value$30.62M
12.12%
Sole
710K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares348K
TypeSH
Market value$14.98M
5.93%
Sole
348K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares175.30K
TypeSH
Market value$14.37M
5.69%
Sole
175.30K
Shared
0.00
None
0.00
ADVISORSHARES TR
SOLEShares1.13M
TypeSH
Market value$11.26M
4.46%
Sole
1.13M
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares138K
TypeSH
Market value$11.01M
4.36%
Sole
138K
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares1.54M
TypeSH
Market value$10.16M
4.02%
Sole
1.54M
Shared
0.00
None
0.00
ALIMERA SCIENCES INC
SOLEShares2.55M
TypeSH
Market value$9.95M
3.94%
Sole
2.55M
Shared
0.00
None
0.00
AVADEL PHARMACEUTICALS PLC
SOLEShares553.06K
TypeSH
Market value$9.34M
3.70%
Sole
553.06K
Shared
0.00
None
0.00
XTANT MED HLDGS INC
SOLEShares7.65M
TypeSH
Market value$8.95M
3.54%
Sole
7.65M
Shared
0.00
None
0.00
CATALYST PHARMACEUTICALS INC
SOLEShares500K
TypeSH
Market value$7.97M
3.15%
Sole
500K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares113K
TypeSH
Market value$7.82M
3.09%
Sole
113K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares140K
TypeSH
Market value$7.66M
3.03%
Sole
140K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares85K
TypeSH
Market value$6.97M
2.76%
Sole
85K
Shared
0.00
None
0.00
OLEMA PHARMACEUTICALS INC
SOLEShares605K
TypeSH
Market value$6.85M
2.71%
Sole
605K
Shared
0.00
None
0.00
SAVARA INC
SOLEShares1.33M
TypeSH
Market value$6.65M
2.63%
Sole
1.33M
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares152.91K
TypeSH
Market value$6.54M
2.59%
Sole
152.91K
Shared
0.00
None
0.00
CYBIN INC
SOLEShares13.95M
TypeSH
Market value$5.77M
2.28%
Sole
13.95M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares405K
TypeSH
Market value$5.57M
2.20%
Sole
405K
Shared
0.00
None
0.00
LARIMAR THERAPEUTICS INC
SOLEShares695K
TypeSH
Market value$5.28M
2.09%
Sole
695K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares208K
TypeSH
Market value$5.22M
2.07%
Sole
208K
Shared
0.00
None
0.00
NEUROGENE INC
SOLEShares100K
TypeSH
Market value$5.09M
2.01%
Sole
100K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares78.10K
TypeSH
Market value$4.77M
1.89%
Sole
78.10K
Shared
0.00
None
0.00
ACHIEVE LIFE SCIENCES INC
SOLEShares835.47K
TypeSH
Market value$3.80M
1.50%
Sole
835.47K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares25K
TypeSH
Market value$3.78M
1.50%
Sole
25K
Shared
0.00
None
0.00
LONGBOARD PHARMACEUTICALS IN
SOLEShares170K
TypeSH
Market value$3.67M
1.45%
Sole
170K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VERA THERAPEUTICS INCSOLE | CL A | 710K | SH | $30.62M 12.12% | 710K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 348K | SH | $14.98M 5.93% | 348K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | PUT | 175.30K | SH | $14.37M 5.69% | 175.30K | 0.00 | 0.00 |
ADVISORSHARES TRSOLE | CALL | 1.13M | SH | $11.26M 4.46% | 1.13M | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 138K | SH | $11.01M 4.36% | 138K | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 1.54M | SH | $10.16M 4.02% | 1.54M | 0.00 | 0.00 |
ALIMERA SCIENCES INCSOLE | COM NEW | 2.55M | SH | $9.95M 3.94% | 2.55M | 0.00 | 0.00 |
AVADEL PHARMACEUTICALS PLCSOLE | SPONSORED ADR | 553.06K | SH | $9.34M 3.70% | 553.06K | 0.00 | 0.00 |
XTANT MED HLDGS INCSOLE | COM NEW | 7.65M | SH | $8.95M 3.54% | 7.65M | 0.00 | 0.00 |
CATALYST PHARMACEUTICALS INCSOLE | COM | 500K | SH | $7.97M 3.15% | 500K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 113K | SH | $7.82M 3.09% | 113K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 140K | SH | $7.66M 3.03% | 140K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 85K | SH | $6.97M 2.76% | 85K | 0.00 | 0.00 |
OLEMA PHARMACEUTICALS INCSOLE | COM | 605K | SH | $6.85M 2.71% | 605K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 1.33M | SH | $6.65M 2.63% | 1.33M | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 152.91K | SH | $6.54M 2.59% | 152.91K | 0.00 | 0.00 |
CYBIN INCSOLE | COM | 13.95M | SH | $5.77M 2.28% | 13.95M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 405K | SH | $5.57M 2.20% | 405K | 0.00 | 0.00 |
LARIMAR THERAPEUTICS INCSOLE | COM | 695K | SH | $5.28M 2.09% | 695K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 208K | SH | $5.22M 2.07% | 208K | 0.00 | 0.00 |
NEUROGENE INCSOLE | COM | 100K | SH | $5.09M 2.01% | 100K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 78.10K | SH | $4.77M 1.89% | 78.10K | 0.00 | 0.00 |
ACHIEVE LIFE SCIENCES INCSOLE | COM | 835.47K | SH | $3.80M 1.50% | 835.47K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 25K | SH | $3.78M 1.50% | 25K | 0.00 | 0.00 |
LONGBOARD PHARMACEUTICALS INSOLE | COM | 170K | SH | $3.67M 1.45% | 170K | 0.00 | 0.00 |
Page 1 of 3